Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Department of Health and Human Services (HHS), to accelerate development of its Zika mRNA vaccine
doi:10.1038/s41380-020-00981-3
1991 (landmark Italian trial): A double-blind, placebo-controlled trial involving 130 patients with Alzheimer's disease demonstrated that one year of ALCAR treatment resulted in a slower rate of deterioration compared to placebo across 13 of 14 outcome measures, including significant improvements in the Blessed Dementia Scale, logical intelligence, verbal critical abilities, long-term verbal memory, and selective attention [5][17]
PubMed laboratory research record [PMID: 30714450] PubMed record related to this compound for laboratory literature review
US$ 23.45
US$ 21.18
US$ 22.77
US$ 23.98
US$ 27.81
US$ 26.41
US$ 29.72
US$ 22.09
